✦ LIBER ✦

101 PRESURGICAL SUNITINIB IN METASTATIC CLEAR CELL RENAL CANCER (MRCC): SURGICAL SAFETY AND EFFECT ON THE PRIMARY TUMOUR

✍ Scribed by T. Powles; J. Peters; S. Horenblas; W. Meinhardt; T. O'Brien; A. Sahdev; L. Lim; J. Green; S. Chowdhury; V. Nargund; J. Bycroft; J. Hannen; A. Bex

Book ID: 119620844
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 220 KB
Volume: 9
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(10)60107-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Study of Presurgical Sunitini

A Phase II Study of Presurgical Sunitinib in Patients With Metastatic Clear-cell Renal Carcinoma and the Primary Tumor In Situ

✍ Axel Bex; Christian Blank; Wim Meinhardt; Harm van Tinteren; Simon Horenblas; Jo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 436 KB

197 The effect of anti-VEGF tyrosine kin

197 The effect of anti-VEGF tyrosine kinase inhibitors on biomarkers and tumour heterogeneity in metastatic clear cell renal cancer

✍ Stewart, G.D.; Laird, A.; O'Mahony, F.C.; Eory, L.; Lubbock, A.L.R.; Nanda, J.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 111 KB